1. Schaffer AP, Larson RL, Cernicchiaro N, et al. The association between calfhood bovine respiratory disease complex and subsequent departure from the herd, milk production, and reproduction in dairy cattle. J Am Vet Med Assoc 2016; 248: 1157–1164.

• Crossref
1. Schaffer AP, Larson RL, Cernicchiaro N, et al. The association between calfhood bovine respiratory disease complex and subsequent departure from the herd, milk production, and reproduction in dairy cattle. J Am Vet Med Assoc 2016; 248: 1157–1164.10.2460/javma.248.10.1157)| false
• Search Google Scholar
• Export Citation

2. Virtala AM, Mechor GD, Gröhn YT, et al. The effect of calfhood diseases on growth of female dairy calves during the first 3 months of life in New York State. J Dairy Sci 1996; 79: 1040–1049.

• Crossref
2. Virtala AM, Mechor GD, Gröhn YT, et al. The effect of calfhood diseases on growth of female dairy calves during the first 3 months of life in New York State. J Dairy Sci 1996; 79: 1040–1049.10.3168/jds.S0022-0302(96)76457-3)| false
• Search Google Scholar
• Export Citation

3. Donovan GA, Dohoo IR, Montgomery DM, et al. Calf and disease factors affecting growth in female Holstein calves in Florida, USA. Prev Vet Med 1998; 33: 1–10.

• Crossref
3. Donovan GA, Dohoo IR, Montgomery DM, et al. Calf and disease factors affecting growth in female Holstein calves in Florida, USA. Prev Vet Med 1998; 33: 1–10.10.1016/S0167-5877(97)00059-7)| false
• Search Google Scholar
• Export Citation

4. Extralabel drug use in animals. 21 CFR 530.

4. Extralabel drug use in animals. 21 CFR 530.)| false
• Search Google Scholar
• Export Citation

5. FDA. Guidance for Industry #207. Studies to evaluate the metabolism and residue kinetics of veterinary drugs in food-producing animals: marker residue depletion studies to establish product withdrawal periods. March 2015. Available at: www.fda.gov/downloads/AnimalVeterinary/GuidanceComplianceEnforcement/GuidanceforIndustry/UCM207941.pdf. Accessed Jul 23, 2016.

5. FDA. Guidance for Industry #207. Studies to evaluate the metabolism and residue kinetics of veterinary drugs in food-producing animals: marker residue depletion studies to establish product withdrawal periods. March 2015. Available at: www.fda.gov/downloads/AnimalVeterinary/GuidanceComplianceEnforcement/GuidanceforIndustry/UCM207941.pdf. Accessed Jul 23, 2016.)| false
• Search Google Scholar
• Export Citation

6. FDA. Guidance for Industry #191. Changes to approved NADAs—new NADAs vs category II supplemental NADAs. May 2015. Available at: www.fda.gov/downloads/AnimalVeterinary/GuidanceComplianceEnforcement/GuidanceforIndustry/ucm052460.pdf. Accessed Jan 20, 2016.

6. FDA. Guidance for Industry #191. Changes to approved NADAs—new NADAs vs category II supplemental NADAs. May 2015. Available at: www.fda.gov/downloads/AnimalVeterinary/GuidanceComplianceEnforcement/GuidanceforIndustry/ucm052460.pdf. Accessed Jan 20, 2016.)| false
• Search Google Scholar
• Export Citation

7. Stobo IJ, Roy JH, Gaston HJ. Rumen development in the calf. 2. The effect of diets containing different proportions of concentrates to hay on digestive efficiency. Br J Nutr 1966; 20: 189–215.

• Crossref
7. Stobo IJ, Roy JH, Gaston HJ. Rumen development in the calf. 2. The effect of diets containing different proportions of concentrates to hay on digestive efficiency. Br J Nutr 1966; 20: 189–215.10.1079/BJN19660022)| false
• Search Google Scholar
• Export Citation

8. Drackley JK. Calf nutrition from birth to breeding. Vet Clin North Am Food Anim Pract 2008; 24: 55–86.

• Crossref
8. Drackley JK. Calf nutrition from birth to breeding. Vet Clin North Am Food Anim Pract 2008; 24: 55–86.10.1016/j.cvfa.2008.01.001)| false
• Search Google Scholar
• Export Citation

9. Toutain PL, Ferran A, Bousquet-Mélou A. Species differences in pharmacokinetics and pharmacodynamics. In: Cunningham F, Elliott J, Lees P eds. Comparative and veterinary pharmacology. Berlin, Germany: Springer-Verlag, 2010; 19–48.

9. Toutain PL, Ferran A, Bousquet-Mélou A. Species differences in pharmacokinetics and pharmacodynamics. In: Cunningham F, Elliott J, Lees P eds. Comparative and veterinary pharmacology. Berlin, Germany: Springer-Verlag, 2010; 19–48.)| false
• Search Google Scholar
• Export Citation

10. Brown SA, Chester ST, Robb EJ. Effects of age on the pharmacokinetics of single dose ceftiofur sodium administered intramuscularly or intravenously to cattle. J Vet Pharmacol Ther 1996; 19: 32–38.

• Crossref
10. Brown SA, Chester ST, Robb EJ. Effects of age on the pharmacokinetics of single dose ceftiofur sodium administered intramuscularly or intravenously to cattle. J Vet Pharmacol Ther 1996; 19: 32–38.10.1111/j.1365-2885.1996.tb00005.x)| false
• Search Google Scholar
• Export Citation

11. Kissell LW, Brinson PD, Gehring R, et al. Pharmacokinetics and tissue elimination of flunixin in veal calves. Am J Vet Res 2016; 77: 634–640.

• Crossref
11. Kissell LW, Brinson PD, Gehring R, et al. Pharmacokinetics and tissue elimination of flunixin in veal calves. Am J Vet Res 2016; 77: 634–640.10.2460/ajvr.77.6.634)| false
• Search Google Scholar
• Export Citation

12. Gips M, Soback S. Norfloxacin nicotinate pharmacokinetics in unweaned and weaned calves. J Vet Pharmacol Ther 1996; 19: 130–134.

• Crossref
12. Gips M, Soback S. Norfloxacin nicotinate pharmacokinetics in unweaned and weaned calves. J Vet Pharmacol Ther 1996; 19: 130–134.10.1111/j.1365-2885.1996.tb00025.x)| false
• Search Google Scholar
• Export Citation

13. Kaartinen L, Pyörülü S, Moialen M, et al. Pharmacokinetics of enrofloxacin in newborn and one-week old calves. J Vet Pharmacol Ther 1997; 20: 479–482.

• Crossref
13. Kaartinen L, Pyörülü S, Moialen M, et al. Pharmacokinetics of enrofloxacin in newborn and one-week old calves. J Vet Pharmacol Ther 1997; 20: 479–482.10.1046/j.1365-2885.1997.00100.x)| false
• Search Google Scholar
• Export Citation

14. Nouws JF, Vree TB, Degen M, et al. Pharmacokinetics of sulphamethoxazole in calves and cows. Vet Q 1991; 13: 10–15.

• Crossref
14. Nouws JF, Vree TB, Degen M, et al. Pharmacokinetics of sulphamethoxazole in calves and cows. Vet Q 1991; 13: 10–15.10.1080/01652176.1991.9694279)| false
• Search Google Scholar
• Export Citation

15. Lichtenwalner DM, Cameron BD, Young C. The metabolism and pharmacokinetics of flunixin in cows and steers, in Proceedings. 14th World Cong Dis Cattle 1986; 1179–1183.

15. Lichtenwalner DM, Cameron BD, Young C. The metabolism and pharmacokinetics of flunixin in cows and steers, in Proceedings. 14th World Cong Dis Cattle 1986; 1179–1183.)| false
• Search Google Scholar
• Export Citation

16. Waxman Dova S, Albarellos G, Kreil V, et al. Comparative pharmacokinetics of an injectable cephalexin suspension in beef cattle. Res Vet Sci 2008; 85: 570–574.

• Crossref
16. Waxman Dova S, Albarellos G, Kreil V, et al. Comparative pharmacokinetics of an injectable cephalexin suspension in beef cattle. Res Vet Sci 2008; 85: 570–574.10.1016/j.rvsc.2008.02.012)| false
• Search Google Scholar
• Export Citation

17. Riviere JE. Principles of drug movement in the body. In: Riviere JE, ed. Comparative pharmacokinetics: principles, techniques and applications. 2nd ed. Ames, Iowa: Wiley-Blackwell, 2011; 13–25.

17. Riviere JE. Principles of drug movement in the body. In: Riviere JE, ed. Comparative pharmacokinetics: principles, techniques and applications. 2nd ed. Ames, Iowa: Wiley-Blackwell, 2011; 13–25.)| false
• Search Google Scholar
• Export Citation

18. Ionescu C, Caira MR. Pathways of biotransformation—phase I reactions. In: Drug metabolism: current concepts. Dordrecht, The Netherlands: Springer Netherlands, 2005; 41–128.

18. Ionescu C, Caira MR. Pathways of biotransformation—phase I reactions. In: Drug metabolism: current concepts. Dordrecht, The Netherlands: Springer Netherlands, 2005; 41–128.)| false
• Search Google Scholar
• Export Citation

19. Gibson GG, Skett P. Pathways of drug metabolism. In: Introduction to drug metabolism. 3rd ed. Cheltenham, England: Nelson Thornes Ltd, 2001:1–37.

19. Gibson GG, Skett P. Pathways of drug metabolism. In: Introduction to drug metabolism. 3rd ed. Cheltenham, England: Nelson Thornes Ltd, 2001:1–37.)| false
• Search Google Scholar
• Export Citation

20. Shoaf SE, Schwark WS, Guard CL, et al. The development of hepatic drug-metabolizing enzyme activity in the neonatal calf and its effect on drug disposition. Drug Metab Dispos 1987; 15: 676–681.

20. Shoaf SE, Schwark WS, Guard CL, et al. The development of hepatic drug-metabolizing enzyme activity in the neonatal calf and its effect on drug disposition. Drug Metab Dispos 1987; 15: 676–681.)| false
• Search Google Scholar
• Export Citation

21. Schwark WS. Factors that affect drug disposition in food-producing animals during maturation. J Anim Sci 1992; 70: 3635–3645.

• Crossref
21. Schwark WS. Factors that affect drug disposition in food-producing animals during maturation. J Anim Sci 1992; 70: 3635–3645.10.2527/1992.70113635x)| false
• Search Google Scholar
• Export Citation

22. Alcorn J, McNamara PJ. Ontogeny of hepatic and renal systemic clearance pathways in infants: part I. Clin Pharmacokinet 2002; 41: 959–998.

• Crossref
22. Alcorn J, McNamara PJ. Ontogeny of hepatic and renal systemic clearance pathways in infants: part I. Clin Pharmacokinet 2002; 41: 959–998.10.2165/00003088-200241120-00003)| false
• Search Google Scholar
• Export Citation

23. Alcorn J, McNamara PJ. Ontogeny of hepatic and renal systemic clearance pathways in infants: part II. Clin Pharmacokinet 2002; 41: 1077–1094.

• Crossref
23. Alcorn J, McNamara PJ. Ontogeny of hepatic and renal systemic clearance pathways in infants: part II. Clin Pharmacokinet 2002; 41: 1077–1094.10.2165/00003088-200241130-00005)| false
• Search Google Scholar
• Export Citation

24. Fernandez E, Perez R, Hernandez A, et al. Factors and mechanisms for pharmacokinetic differences between pediatric population and adults. Pharmaceutics 2011; 3: 53–72.

• Crossref
24. Fernandez E, Perez R, Hernandez A, et al. Factors and mechanisms for pharmacokinetic differences between pediatric population and adults. Pharmaceutics 2011; 3: 53–72.10.3390/pharmaceutics3010053)| false
• Search Google Scholar
• Export Citation

25. Wrenn TR, Cecil HC, Connolly MR, et al. Extracellular body water of growing calves as measured by thiocyanate space. J Dairy Sci 1962; 45: 205–209.

• Crossref
25. Wrenn TR, Cecil HC, Connolly MR, et al. Extracellular body water of growing calves as measured by thiocyanate space. J Dairy Sci 1962; 45: 205–209.10.3168/jds.S0022-0302(62)89367-9)| false
• Search Google Scholar
• Export Citation

26. Sekine J, Fujita K, Asahida Y. A prediction of body water compartments of growing cattle in vivo. Asian Aust J Anim 1992; 5: 7–11.

• Crossref
26. Sekine J, Fujita K, Asahida Y. A prediction of body water compartments of growing cattle in vivo. Asian Aust J Anim 1992; 5: 7–11.10.5713/ajas.1992.7)| false
• Search Google Scholar
• Export Citation

27. Toutain PL, Bousquet-Mélou A. Volumes of distribution. J Vet Pharmacol Ther 2004; 27: 441–453.

• Crossref
27. Toutain PL, Bousquet-Mélou A. Volumes of distribution. J Vet Pharmacol Ther 2004; 27: 441–453.10.1111/j.1365-2885.2004.00602.x)| false
• Search Google Scholar
• Export Citation

28. Monti DJ. AMDUCA regulates small and large animal practice. J Am Vet Med Assoc 2000; 216: 1889.

28. Monti DJ. AMDUCA regulates small and large animal practice. J Am Vet Med Assoc 2000; 216: 1889.)| false
• Search Google Scholar
• Export Citation

29. FDA. Guidance for industry #3. General principles for evaluating the human food safety of new animal drugs used in food-producing animals. Draft revised guidance. July 2016. Available at: www.fda.gov/downloads/AnimalVeterinary/GuidanceComplianceEnforcement/GuidanceforIndustry/ucm052180.pdf. Accessed Dec 13, 2016.

29. FDA. Guidance for industry #3. General principles for evaluating the human food safety of new animal drugs used in food-producing animals. Draft revised guidance. July 2016. Available at: www.fda.gov/downloads/AnimalVeterinary/GuidanceComplianceEnforcement/GuidanceforIndustry/ucm052180.pdf. Accessed Dec 13, 2016.)| false
• Search Google Scholar
• Export Citation

30. USDA Food Safety and Inspection Service. Screening and confirmation of animal drug residues by UHPLC-MS-MS Available at: www.fsis.usda.gov/wps/wcm/connect/b9d45c8b-74d4-4e99-8eda-5453812eb237/CLG-MRM1.pdf?MOD=AJPERES. Accessed Sep 26, 2016.

30. USDA Food Safety and Inspection Service. Screening and confirmation of animal drug residues by UHPLC-MS-MS Available at: www.fsis.usda.gov/wps/wcm/connect/b9d45c8b-74d4-4e99-8eda-5453812eb237/CLG-MRM1.pdf?MOD=AJPERES. Accessed Sep 26, 2016.)| false
• Search Google Scholar
• Export Citation

31. FARAD. Extralabel drug use (ELDU) resource page. Available at: www.farad.org/eldu/eldumain.asp. Accessed Dec 14, 2016.

31. FARAD. Extralabel drug use (ELDU) resource page. Available at: www.farad.org/eldu/eldumain.asp. Accessed Dec 14, 2016.)| false
• Search Google Scholar
• Export Citation

32. North American Compendiums Inc. Compendium of veterinary products (CVP) electronic database. Available at: bayer-all.naccvp.com/?u=bayer&p=dvm. Accessed Dec 14, 2016.

32. North American Compendiums Inc. Compendium of veterinary products (CVP) electronic database. Available at: bayer-all.naccvp.com/?u=bayer&p=dvm. Accessed Dec 14, 2016.)| false
• Search Google Scholar
• Export Citation

33. FDA. Animal drugs @ FDA. Available at: www.accessdata.fda.gov/scripts/animaldrugsatfda/details.cfm?dn=140-338. Accessed Dec 14, 2016.

33. FDA. Animal drugs @ FDA. Available at: www.accessdata.fda.gov/scripts/animaldrugsatfda/details.cfm?dn=140-338. Accessed Dec 14, 2016.)| false
• Search Google Scholar
• Export Citation

34. Vetgram FARAD. Available at: www.farad.org/vetgram/search.asp. Accessed Dec 14, 2016.

35. USDA National Animal Health Monitoring System. Dairy 2014. Dairy Cattle Management Practices in the United States, 2014. Available at: www.aphis.usda.gov/animal_health/nahms/dairy/downloads/dairy14/Dairy14_dr_PartI.pdf. Accessed Dec 14, 2016.

35. USDA National Animal Health Monitoring System. Dairy 2014. Dairy Cattle Management Practices in the United States, 2014. Available at: www.aphis.usda.gov/animal_health/nahms/dairy/downloads/dairy14/Dairy14_dr_PartI.pdf. Accessed Dec 14, 2016.)| false
• Search Google Scholar
• Export Citation

36. Smith G. Antimicrobial decision making for enteric diseases of cattle. Vet Clin North Am Food Anim Pract 2015; 31: 47–60.

• Crossref
36. Smith G. Antimicrobial decision making for enteric diseases of cattle. Vet Clin North Am Food Anim Pract 2015; 31: 47–60.10.1016/j.cvfa.2014.11.004)| false
• Search Google Scholar
• Export Citation

37. New animal drugs for use in animal feeds; oxytetracycline; neomycin. 21 CFR 558.

37. New animal drugs for use in animal feeds; oxytetracycline; neomycin. 21 CFR 558.)| false
• Search Google Scholar
• Export Citation

38. USDA Food Safety and Inspection Service. United States national residue program for meat, poultry, and egg products. 2014 residue sample results. Available at: www.fsis.usda.gov/wps/wcm/connect/2428086b-f8ec-46ed-8531-a45d10bfef6f/2014-Red-Book.pdf?MOD=AJPERES. Accessed Dec 13, 2016.

38. USDA Food Safety and Inspection Service. United States national residue program for meat, poultry, and egg products. 2014 residue sample results. Available at: www.fsis.usda.gov/wps/wcm/connect/2428086b-f8ec-46ed-8531-a45d10bfef6f/2014-Red-Book.pdf?MOD=AJPERES. Accessed Dec 13, 2016.)| false
• Search Google Scholar
• Export Citation

39. Paige JC, Pell F. Drug residues in food producing animals. FDA Veterinarian 1997; 12.

39. Paige JC, Pell F. Drug residues in food producing animals. FDA Veterinarian 1997; 12.)| false
• Search Google Scholar
• Export Citation

40. Rangel-Lugo M, Payne M, Webb AI, et al. Prevention of antibiotic residues in veal calves fed colostrum. J Am Vet Med Assoc 1998; 213: 40–42.

40. Rangel-Lugo M, Payne M, Webb AI, et al. Prevention of antibiotic residues in veal calves fed colostrum. J Am Vet Med Assoc 1998; 213: 40–42.)| false
• Search Google Scholar
• Export Citation

41. Musser JM, Anderson KL, Rushing JE, et al. Potential for milk containing penicillin G or amoxicillin to cause residues in calves. J Dairy Sci 2001; 84: 126–133.

• Crossref
41. Musser JM, Anderson KL, Rushing JE, et al. Potential for milk containing penicillin G or amoxicillin to cause residues in calves. J Dairy Sci 2001; 84: 126–133.10.3168/jds.S0022-0302(01)74460-8)| false
• Search Google Scholar
• Export Citation

42. Musser JM, Anderson KL, Boison JO. Tissue disposition and depletion of penicillin G after oral administration with milk in unweaned dairy calves. J Am Vet Med Assoc 2001; 219: 346–350.

• Crossref
42. Musser JM, Anderson KL, Boison JO. Tissue disposition and depletion of penicillin G after oral administration with milk in unweaned dairy calves. J Am Vet Med Assoc 2001; 219: 346–350.10.2460/javma.2001.219.346)| false
• Search Google Scholar
• Export Citation

43. Guest GB, Paige JC. The magnitude of the tissue residue problem with regard to consumer needs. J Am Vet Med Assoc 1991; 198: 805–808.

43. Guest GB, Paige JC. The magnitude of the tissue residue problem with regard to consumer needs. J Am Vet Med Assoc 1991; 198: 805–808.)| false
• Search Google Scholar
• Export Citation

44. Hausler K, Godden SM, Schneider MJ, et al. Hot topic: investigating the risk of violative meat residues in bob veal calves fed colostrum from cows treated at dry-off with cephapirin benzathine. J Dairy Sci 2013; 96: 2349–2355.

• Crossref
44. Hausler K, Godden SM, Schneider MJ, et al. Hot topic: investigating the risk of violative meat residues in bob veal calves fed colostrum from cows treated at dry-off with cephapirin benzathine. J Dairy Sci 2013; 96: 2349–2355.10.3168/jds.2012-5891)| false
• Search Google Scholar
• Export Citation

45. Adulterated drugs and devices. 21 CFR 501(a)(6) § 351(a)(6).

45. Adulterated drugs and devices. 21 CFR 501(a)(6) § 351(a)(6).)| false
• Search Google Scholar
• Export Citation

46. FDA. Department of Health and Human Services: Warning letter #15-PHI-09. Available at: www.fda.gov/ICECI/EnforcementActions/WarningLetters/ucm432140.htm. Accessed Jan 12, 2017.

46. FDA. Department of Health and Human Services: Warning letter #15-PHI-09. Available at: www.fda.gov/ICECI/EnforcementActions/WarningLetters/ucm432140.htm. Accessed Jan 12, 2017.)| false
• Search Google Scholar
• Export Citation

47. FDA. Veterinary feed directive. Fed Regist 2015; 80: 31708–31735.

47. FDA. Veterinary feed directive. Fed Regist 2015; 80: 31708–31735.)| false
• Search Google Scholar
• Export Citation

48. California State Legislature. SB-27, Hill. Livestock: use of antimicrobial drugs. Available at: leginfo.legislature.ca.gov/faces/billTextClient.xhtml?bill_id=201520160SB27. Accessed Jul 25, 2016.

48. California State Legislature. SB-27, Hill. Livestock: use of antimicrobial drugs. Available at: leginfo.legislature.ca.gov/faces/billTextClient.xhtml?bill_id=201520160SB27. Accessed Jul 25, 2016.)| false
• Search Google Scholar
• Export Citation

49. Romvary A, Sandor G. Distribution and elimination of sulfamethoxazole and N4-sulfamethoxazole in calf and piglet tissues. Acta Vet Scand Suppl 1991; 87: 432–433.

49. Romvary A, Sandor G. Distribution and elimination of sulfamethoxazole and N4-sulfamethoxazole in calf and piglet tissues. Acta Vet Scand Suppl 1991; 87: 432–433.)| false
• Search Google Scholar
• Export Citation

50. Meijer LA, Ceyssens KG, de Jong WT, et al. Correlation between tissue and plasma concentrations of oxytetracycline in veal calves. J Toxicol Environ Health 1993; 40: 35–45.

• Crossref
50. Meijer LA, Ceyssens KG, de Jong WT, et al. Correlation between tissue and plasma concentrations of oxytetracycline in veal calves. J Toxicol Environ Health 1993; 40: 35–45.10.1080/15287399309531774)| false
• Search Google Scholar
• Export Citation

51. Luthman J, Jacobsson SO. The availability of tetracyclines in calves. Nord Vet Med 1983; 35: 292–299.

51. Luthman J, Jacobsson SO. The availability of tetracyclines in calves. Nord Vet Med 1983; 35: 292–299.)| false
• Search Google Scholar
• Export Citation

52. Nouws JF, van Ginneken CA, Ziv G. Age-dependent pharmacokinetics of oxytetracycline in ruminants. J Vet Pharmacol Ther 1983; 6: 59–66.

• Crossref
52. Nouws JF, van Ginneken CA, Ziv G. Age-dependent pharmacokinetics of oxytetracycline in ruminants. J Vet Pharmacol Ther 1983; 6: 59–66.10.1111/j.1365-2885.1983.tb00455.x)| false
• Search Google Scholar
• Export Citation

53. Webster HB, Morin D, Jarrell V, et al. Effects of local anesthesia and flunixin meglumine on the acute cortisol response, behavior, and performance of young dairy calves undergoing surgical castration. J Dairy Sci 2013; 96: 6285–6300.

• Crossref
53. Webster HB, Morin D, Jarrell V, et al. Effects of local anesthesia and flunixin meglumine on the acute cortisol response, behavior, and performance of young dairy calves undergoing surgical castration. J Dairy Sci 2013; 96: 6285–6300.10.3168/jds.2012-6238)| false
• Search Google Scholar
• Export Citation

54. Mintline EM, Varga A, Banuelos J, et al. Healing of surgical castration wounds: a description and an evaluation of flunixin. J Anim Sci 2014; 92: 5659–5665.

• Crossref
54. Mintline EM, Varga A, Banuelos J, et al. Healing of surgical castration wounds: a description and an evaluation of flunixin. J Anim Sci 2014; 92: 5659–5665.10.2527/jas.2014-7885)| false
• Search Google Scholar
• Export Citation

55. Paull DR, Small AH, Lee C, et al. Effect of local infusion of NSAID analgesics administered alone or in combination on the pain associated with band castration in calves. Aust Vet J 2015; 93: 271–277.

• Crossref
55. Paull DR, Small AH, Lee C, et al. Effect of local infusion of NSAID analgesics administered alone or in combination on the pain associated with band castration in calves. Aust Vet J 2015; 93: 271–277.10.1111/avj.12348)| false
• Search Google Scholar
• Export Citation

56. Sidhu PK, Gehring R, Mzyk DA, et al. Avoiding violative flunixin meglumine residues in cattle and swine. J Am Vet Med Assoc 2017; 250: 182–189.

• Crossref
56. Sidhu PK, Gehring R, Mzyk DA, et al. Avoiding violative flunixin meglumine residues in cattle and swine. J Am Vet Med Assoc 2017; 250: 182–189.10.2460/javma.250.2.182)| false
• Search Google Scholar
• Export Citation

57. Glynn HD, Coetzee JF, Edwards-Callaway LN, et al. The pharmacokinetics and effects of meloxicam, gabapentin, and flunixin in postweaning dairy calves following dehorning with local anesthesia. J Vet Pharmacol Ther 2013; 36: 550–561.

• Crossref
57. Glynn HD, Coetzee JF, Edwards-Callaway LN, et al. The pharmacokinetics and effects of meloxicam, gabapentin, and flunixin in postweaning dairy calves following dehorning with local anesthesia. J Vet Pharmacol Ther 2013; 36: 550–561.10.1111/jvp.12042)| false
• Search Google Scholar
• Export Citation

58. Battaller N. FDA communication regarding the use of meloxicam in cattle. Available at: www.aabp.org/members/resources/FDA_Communication_meloxicam_AMDUCA_7.2014.pdf. Accessed Dec 14, 2016.

58. Battaller N. FDA communication regarding the use of meloxicam in cattle. Available at: www.aabp.org/members/resources/FDA_Communication_meloxicam_AMDUCA_7.2014.pdf. Accessed Dec 14, 2016.)| false
• Search Google Scholar
• Export Citation

59. AVMA. AMDUCA extralabel drug use algorithm. Available at: www.avma.org/KB/Resources/Reference/Pages/AMDUCA2.aspx. Accessed Dec 14, 2016.

59. AVMA. AMDUCA extralabel drug use algorithm. Available at: www.avma.org/KB/Resources/Reference/Pages/AMDUCA2.aspx. Accessed Dec 14, 2016.)| false
• Search Google Scholar
• Export Citation

60. Coetzee JF, Mosher RA, Griffith GR, et al. Pharmacokinetics and tissue disposition of meloxicam in beef calves after repeated oral administration. J Vet Pharmacol Ther 2015; 38: 556–562.

• Crossref
60. Coetzee JF, Mosher RA, Griffith GR, et al. Pharmacokinetics and tissue disposition of meloxicam in beef calves after repeated oral administration. J Vet Pharmacol Ther 2015; 38: 556–562.10.1111/jvp.12215)| false
• Search Google Scholar
• Export Citation

61. European Medicines Agency. Annex 1. Summary of product characteristics. Metacam. Available at: www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Product_Information/veterinary/000033/WC500065777.pdf. Accessed Jul 25, 2016.

61. European Medicines Agency. Annex 1. Summary of product characteristics. Metacam. Available at: www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Product_Information/veterinary/000033/WC500065777.pdf. Accessed Jul 25, 2016.)| false
• Search Google Scholar
• Export Citation

62. FDA. Cephalosporin order of prohibition goes into effect. Available at: www.fda.gov/AnimalVeterinary/NewsEvents/CVMUpdates/ucm299054.htm. Accessed Dec 14, 2016.

62. FDA. Cephalosporin order of prohibition goes into effect. Available at: www.fda.gov/AnimalVeterinary/NewsEvents/CVMUpdates/ucm299054.htm. Accessed Dec 14, 2016.)| false
• Search Google Scholar
• Export Citation

63. Drugs prohibited for extralabel use in animals. 21 CFR 530.41.

64. Woodrow JS, Caldwel M, Cox S, et al. Comparative plasma pharmacokinetics of ceftiofur sodium and ceftiofur crystalline-free acid in neonatal calves. J Vet Pharmacol Ther 2016; 39: 271–276.

• Crossref
64. Woodrow JS, Caldwel M, Cox S, et al. Comparative plasma pharmacokinetics of ceftiofur sodium and ceftiofur crystalline-free acid in neonatal calves. J Vet Pharmacol Ther 2016; 39: 271–276.10.1111/jvp.12275)| false
• Search Google Scholar
• Export Citation

65. Foster DM, Jacob ME, Warren CD, et al. Pharmacokinetics of enrofloxacin and ceftiofur in plasma, interstitial fluid, and gastrointestinal tract of calves after subcutaneous injection, and bactericidal impacts on representative enteric bacteria. J Vet Pharmacol Ther 2016; 39: 62–71.

• Crossref
65. Foster DM, Jacob ME, Warren CD, et al. Pharmacokinetics of enrofloxacin and ceftiofur in plasma, interstitial fluid, and gastrointestinal tract of calves after subcutaneous injection, and bactericidal impacts on representative enteric bacteria. J Vet Pharmacol Ther 2016; 39: 62–71.10.1111/jvp.12236)| false
• Search Google Scholar
• Export Citation

66. Merck Animal Health. Nuflor (florfenicol) product label. Madison, NJ: Merck Animal Health Intervet Inc, 2011.

66. Merck Animal Health. Nuflor (florfenicol) product label. Madison, NJ: Merck Animal Health Intervet Inc, 2011.)| false
• Search Google Scholar
• Export Citation

67. FDA. Extralabel animal drug use; fluoroquinolones and glycopeptides; order of prohibition. Fed Regist 1997; 62: 27944–27947.

67. FDA. Extralabel animal drug use; fluoroquinolones and glycopeptides; order of prohibition. Fed Regist 1997; 62: 27944–27947.)| false
• Search Google Scholar
• Export Citation

68. Zoetis. Advocin (danofloxacin injection) product label. Kalamazoo, Mich: Zoetis Inc, 2014.

68. Zoetis. Advocin (danofloxacin injection) product label. Kalamazoo, Mich: Zoetis Inc, 2014.)| false
• Search Google Scholar
• Export Citation

69. Bayer. Baytril (enrofloxacin) product label. Shawnee Mission, Kan: Bayer Healthcare LLC, 2015.

69. Bayer. Baytril (enrofloxacin) product label. Shawnee Mission, Kan: Bayer Healthcare LLC, 2015.)| false
• Search Google Scholar
• Export Citation

70. Tolerances for residues of new animal drugs in food. 21 CFR 556.

70. Tolerances for residues of new animal drugs in food. 21 CFR 556.)| false
• Search Google Scholar
• Export Citation